Can you give an example of a patient in which the failure to initially deploy, but subsequent use of NGS-based, comprehensive molecular profiling led to improvements in their clinical course?

Can you give an example of a patient in which the failure to initially deploy, but subsequent use of NGS-based, comprehensive molecular profiling led to improvements in their clinical course?

Can you give us a specific example of a patient in which the failure to initially deploy, but then subsequent use of NGS-based, comprehensive molecular profiling led to documented improvements in their clinical course based on identification of targeted agent?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Dr. Wong Seng Weng, MBBS, MRCP(UK), FAMS (Medical Oncology)

Dr. Wong Seng Weng, MBBS, MRCP(UK), FAMS (Medical Oncology)

Medical Director & Consultant Medical Oncologist
The Cancer Centre (Singapore Medical Group)
Paragon Medical & Mt Elizabeth Novena
Specialist Centre Visiting Consultant
Mt Elizabeth Hospital & Mt Elizabeth Novena Hospital